发明名称 ácido r-7-(3-aminometil-4-metóxi-imino-3-metil-pirrolidin-1-1il)-1-ciclopropil-6-fluoro-4-oxo-1,4-di-hidro-[1,8]naftiridina-3-carboxílico e sal do ácido aspártico, processo para a preparação dos mesmos e composição farmacêutica que compreende os mesmos para antimicrobiano
摘要 Disclosed herein are R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial. Because the R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt is more soluble and less toxic and has less side effects as an antimicrobial agent than hydrochloride and the other salts (D-aspartate and phosphate) conventionally used, the salt may be useful for oral and injectable administration.
申请公布号 BR112012001897(A2) 申请公布日期 2016.03.15
申请号 BR20121101897 申请日期 2010.07.27
申请人 ARIMED, INC. 发明人 DONG RACK CHOI;JEI MAN RYU;JIN YANG;SEUNG HWAN KIM;SEUNG-KYOO SEONG;SUE HYE YOON;SUNG JAE PYUN
分类号 A61K31/445;A61P31/00;C07D403/04;C07D487/04 主分类号 A61K31/445
代理机构 代理人
主权项
地址